Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council [Yahoo! Finance]
Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council
Cibus (NASDAQ:CBUS) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $15.00 price target on the stock.
Earnings To Watch: Cibus Inc (CBUS) Reports Q3 2025 Result [Yahoo! Finance]
Cibus Announces the Election of Craig Wichner to Board of Directors [Yahoo! Finance]